ADDvise receives order worth USD 1.8 million

Report this content

ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Cordeel, a multinational construction company. The order is worth approximately USD 1.8 million and involves construction of cleanrooms for a pharmaceutical production facility in Bulgaria for TEVA Pharmaceutical. Delivery of the order is planned to take place during Q3 2022.

- The market sentiment in the laboratory and cleanroom industry is very strong. Pharmaceutical companies risk appetite is growing which makes the sales cycles shorter. The inquiry rate is now very high which gives us good visibility, says Rikard Akhtarzand CEO of ADDvise Group AB.

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71

Important information:

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on 2 November 2021 at 16:15 CET.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50,, is the Company's Certified Adviser. Additional information is available at